Dimension Biotechnologies
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dimension Biotechnologies - overview
Established
2025
Location
-, -, UK
Primary Industry
Biotechnology
About
Founded in 2025 and based in Bristol, UK, Dimension Biotechnologies provides blood-based microvascular health analysis technology and glycocalyx biomarker testing solutions.
Current Investors
Kidney Research UK, University of Bristol, The Francis Crick Institute Limited
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.dimensionbio.tech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Dimension Biotechnologies - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unspecified Round | Completed | Dimension Biotechnologies | - | ||||||||
| Grant | Completed | Dimension Biotechnologies | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.